PROMETHAZINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Promethazine Hydrochloride, and when can generic versions of Promethazine Hydrochloride launch?
Promethazine Hydrochloride is a drug marketed by Abbott, Am Regent, Bedford Labs, Epic Pharma Llc, Hospira, Marsam Pharms Llc, Mylan Institutional, Sandoz, Teva Pharms Usa, Watson Labs, West-ward Pharms Int, Wockhardt, Xgen Pharms, Able, Annora Pharma, Cosette, Padagis Israel, Taro, Watson Labs Inc, Amneal Pharms, Chartwell Rx, Kv Pharm, Nostrum Labs Inc, Pharm Assoc, Quagen, Tris Pharma Inc, Whiteworth Town Plsn, Amneal Pharms Ny, Aurobindo Pharma Usa, Chartwell Molecular, Impax Labs, Invatech, Ivax Sub Teva Pharms, Kvk Tech, Prinston Inc, Pvt Form, Strides Pharma, Sun Pharm Inds Inc, Sun Pharm Industries, Tablicaps, Teva, Zydus Pharms Usa, Actavis Mid Atlantic, Hikma, Wockhardt Bio Ag, and Ani Pharms. and is included in ninety NDAs.
The generic ingredient in PROMETHAZINE HYDROCHLORIDE is codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride. There are nineteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROMETHAZINE HYDROCHLORIDE?
- What are the global sales for PROMETHAZINE HYDROCHLORIDE?
- What is Average Wholesale Price for PROMETHAZINE HYDROCHLORIDE?
Summary for PROMETHAZINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 46 |
NDAs: | 90 |
Finished Product Suppliers / Packagers: | 50 |
Raw Ingredient (Bulk) Api Vendors: | 123 |
Clinical Trials: | 58 |
Patent Applications: | 2,392 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PROMETHAZINE HYDROCHLORIDE at DailyMed |
![PROMETHAZINE HYDROCHLORIDE drug patent expirations Drug patent expirations by year for PROMETHAZINE HYDROCHLORIDE](/p/graph/s/t/PROMETHAZINE_HYDROCHLORIDE-patent-expirations.png)
Recent Clinical Trials for PROMETHAZINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Trauma Center | N/A |
Oman Medical Speciality Board | Phase 3 |
Tanta University | N/A |
Pharmacology for PROMETHAZINE HYDROCHLORIDE
Drug Class | Phenothiazine |
Medical Subject Heading (MeSH) Categories for PROMETHAZINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for PROMETHAZINE HYDROCHLORIDE
US Patents and Regulatory Information for PROMETHAZINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Invatech | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | TABLET;ORAL | 085146-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Tablicaps | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | TABLET;ORAL | 084027-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Amneal Pharms | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | SYRUP;ORAL | 040882-001 | Dec 30, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Annora Pharma | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | SUPPOSITORY;RECTAL | 216446-002 | Nov 2, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |